Is there a recognised cardio-oncology group or society in your country?
Spain has a well-established cardio-oncology community that actively promotes the development of specialised services, clinical pathways, education, and research nationwide. Working in close collaboration with national scientific societies, the group supports the implementation of multidisciplinary strategies aimed at improving cardiovascular care for patients with cancer.
Clinical Practice
The Spanish cardio-oncology community plays a central role in supporting the development of clinical pathways for baseline cardiovascular risk assessment, prevention, early detection, and management of cancer therapy-related cardiovascular toxicity.
Several centres across Spain have established dedicated cardio-oncology clinics or multidisciplinary care pathways involving cardiology, medical oncology, haematology, radiation oncology, nursing, and primary care professionals when appropriate. These collaborative models facilitate comprehensive patient management throughout the cancer care continuum.
The group also promotes national implementation strategies led by the Spanish Society of Cardiology (SEC) in partnership with the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Radiation Oncology (SEOR), the Spanish Society of Haematology and Haemotherapy (SEHH), and the Spanish Society of Primary Care Physicians (SEMERGEN). These initiatives include SEC–Primary Care projects in cardio-oncology, activities related to occupational medicine, and the SEC-Excelente programme in cardio-oncology, which aims to support quality standards and certification of excellence for cardio-oncology units across the country.
These efforts are closely aligned with the 2022 ESC Cardio-Oncology Guidelines and contribute to the continued development of structured, multidisciplinary care for patients with cancer in Spain.
Education
Cardio-oncology education is highly developed in Spain and benefits from strong national engagement. One of the flagship educational initiatives is CardioTox, the national cardio-oncology congress, which has become a leading forum for healthcare professionals involved in the cardiovascular care of patients with cancer. The congress will celebrate its 12th edition in 2026 and serves as an important platform for scientific exchange and professional development.
In addition, cardio-oncology is consistently represented within the educational programmes of the Spanish Society of Cardiology, including the National Residents’ Congress and a broad range of lectures, interviews, and educational sessions delivered through SEC communication and learning platforms.
These initiatives aim to increase awareness of cardio-oncology, strengthen professional training, and facilitate the implementation of guideline-based multidisciplinary care throughout Spain. Through continuous educational activities, the Spanish cardio-oncology community continues to support the development of expertise among cardiologists, oncologists, haematologists, nurses, and other healthcare professionals involved in cancer care.
Research
Spain has been actively contributing to cardio-oncology research and scientific development for more than a decade. Since 2015, the national group has promoted numerous research initiatives and consensus documents, including influential publications in the Revista Española de Cardiología.
The group has also supported national collaborative research projects and registries, including the SIR-CVT Registry, led by the Spanish Society of Cardiology in collaboration with SEOM and the Spanish National Centre for Cardiovascular Research (CNIC). This initiative focuses on the study of cardiovascular toxicity related to cancer therapies and contributes valuable data to improve patient care and outcomes.
In addition, the group has participated in the analysis of national cardio-oncology activity through the RECALCAR programme, which has provided important insights into the organisation, implementation, and development of cardio-oncology services across Spain. These initiatives support evidence generation, quality improvement, benchmarking, and the continued expansion of structured cardio-oncology programmes at a national level.
Ongoing research efforts continue to strengthen Spain’s position within the international cardio-oncology community and contribute to the advancement of multidisciplinary, evidence-based care for patients with cancer.
